GLAND - Swing Trade Analysis with AI Signals
Back to List📊 Swing Trade Rating: 4.0
| Stock Code | GLAND | Market Cap | 29,908 Cr. | Current Price | 1,816 ₹ | High / Low | 2,131 ₹ |
| Stock P/E | 25.2 | Book Value | 610 ₹ | Dividend Yield | 0.99 % | ROCE | 15.8 % |
| ROE | 11.6 % | Face Value | 1.00 ₹ | DMA 50 | 1,744 ₹ | DMA 200 | 1,767 ₹ |
| Chg in FII Hold | -0.29 % | Chg in DII Hold | 0.37 % | PAT Qtr | 326 Cr. | PAT Prev Qtr | 302 Cr. |
| RSI | 59.1 | MACD | 15.6 | Volume | 1,10,767 | Avg Vol 1Wk | 1,14,793 |
| Low price | 1,383 ₹ | High price | 2,131 ₹ | PEG Ratio | -7.35 | Debt to equity | 0.00 |
| 52w Index | 57.8 % | Qtr Profit Var | 10.4 % | EPS | 71.0 ₹ | Industry PE | 30.2 |
GLAND shows balanced fundamentals and technicals, making it a reasonable candidate for swing trading. The stock trades at a P/E of 25.2, below the industry average of 30.2, suggesting fair valuation. EPS of ₹71 and consistent quarterly profit growth (+10.4%) add strength. Technical indicators (RSI 59.1, MACD 15.6) show moderate bullish momentum. The optimal entry price would be near the 50 DMA level of ₹1,740–1,760. If already holding, consider exiting around ₹2,050–2,100, close to resistance levels.
✅ Positive
- P/E ratio (25.2) lower than industry average (30.2), indicating fair valuation.
- Quarterly PAT growth from ₹302 Cr. to ₹326 Cr. (+10.4%).
- Strong EPS of ₹71 supports earnings stability.
- Zero debt-to-equity ratio ensures financial safety.
- DII holdings increased (+0.37%), showing domestic investor confidence.
⚠️ Limitation
- ROCE (15.8%) and ROE (11.6%) are moderate compared to high-growth peers.
- Negative PEG ratio (-7.35) indicates valuation concerns relative to growth expectations.
- FII holdings decreased (-0.29%), reflecting cautious foreign sentiment.
📉 Company Negative News
- Slight decline in foreign institutional investor holdings.
- Moderate profitability ratios compared to industry leaders.
📈 Company Positive News
- Consistent quarterly profit growth (+10.4%).
- Domestic institutional investors increased holdings.
- Valuation remains attractive compared to industry peers.
🏭 Industry
- Industry P/E is 30.2, higher than GLAND’s 25.2, suggesting relative undervaluation.
- Pharmaceutical sector benefits from long-term demand and global opportunities.
🔎 Conclusion
GLAND is a fundamentally stable and fairly valued stock, suitable for swing trading. Entry near ₹1,740–1,760 offers a favorable setup, while profit booking should be considered around ₹2,050–2,100. Traders should monitor institutional activity and growth outlook for sustained momentum.